Exchange: NASDAQ·Updated 04:41 PM EDT

KARD Kardigan Inc.

$14.67
$0.47
(3.31%)
Today
Closed $14.67
$0.00
(0.00%)
After Hours
EarningsNov 9
Mkt Cap$1.33B
Vol740,191.00

About KARD

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
52

Neutral Sentiment

How do you feel about KARD?

JFais
$KARD - oversold IPO added to DD list, triumvirate of phase 2 readouts 1H 27 *Hat tip to Houbi in Chat for flagging
mktrdr59
$KARD reached measured move price projections of two degrees with bullish divergences at today's low

Advertisement|Remove ads.